Bio/Pharma News

Sun Pharma to Acquire Ranbaxy

April 07, 2014

Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.

FDA Approves Auto-Injector to Reverse Opioid Overdose

April 03, 2014

Evzio, the first naloxone treatment specifically designed to administered to opioid overdose patients by family members or caregivers, approved in 15 weeks.

Baxter to Split Into Biopharmaceuticals and Medical Products Companies

March 27, 2014

Baxter announces plans to split into two independent companies by mid-2015.

FDA approves Novartis' Xolair for Rare Skin Disease

March 24, 2014

FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.

FDA Approves AstraZeneca Once-Weekly, Pen-Injector Diabetes Treatment

March 05, 2014

FDA approves the extended-release Bydureon Pen for the treatment of type 2 diabetes.

Report: Branded Biopharms Most Exposed to Biosimilar Competition

February 26, 2014

Moody's Investor Service reports AbbVie, Amgen, and Roche are the most exposed to biosimilar competition.

FDA Approves Orphan Drug Myalept

February 26, 2014

FDA approves the orphan drug Myalept for the treatment of leptin deficiency.

Nuevolution Enters License Agreement with Merck

February 25, 2014

Nuevolution enters a license agreement with a subsidiary of Merck for small molecule compounds.

Actavis to Acquire Forest Laboratories

February 19, 2014

The combined company will create blockbuster product franchises in the central nervous system, gastroenterology, women's health, urology, and cardiovascular therapeutic categories.

EMD Serono Appoints New Leaders

February 19, 2014

EMD Serono assigns operational changes.